When it comes to prescribing an H2-receptor antagonist for your active duodenal ulcer patients, there are many options to choose from. Some patients may benefit from the only oral liquid form of nizatidine available.
Whether it’s a newly diagnosed patient or patient you’re switching from another medication, consider Axid Oral Solution, indicated for patients 12 years of age and older. More than 90% of eligible commercially insured patients may pay as little as $5 for their prescription*.
Nizatidine oral solution is contraindicated in patients with known hypersensitivity to the drug or with a history of hypersensitivity to other H2-receptor antagonists. Symptomatic response to nizatidine therapy does not preclude the presence of gastric malignancy. Because nizatidine is excreted primarily by the kidney, dosage should be reduced in patients with moderate to severe renal insufficiency.
For more information please visit Axid.com/AAP2021.
*Terms and conditions apply.